Juicebox avatar

Dexa/Juicebox

Learn more
Published Mar 12, 2021

#452 Learning about Teplizumab

Francisco Leon, co-founder of Provention Bio, delves into his journey in autoimmune research, the groundbreaking impact of teplizumab on type 1 diabetes treatment, and the role of viruses and early interventions in advancing health outcomes.
Episode Highlights
Juicebox Podcast: Type 1 Diabetes logo

Topics covered

Popular Clips

Questions from this episode

Episode Highlights

  • Personal Journey

    shares his deeply personal journey into the world of autoimmune diseases, driven by his mother's battle with kidney failure. Her experience with a rejected kidney transplant profoundly impacted him, leading him to pursue a career in medical research and clinical immunology 1. He explains, "I just couldn't understand why would the immune system reject perfectly functioning kidneys and condemn her to a life tied to a machine?"

    I just couldn't understand why would the immune system reject perfectly functioning kidneys and condemn her to a life tied to a machine?

    ---

    This personal connection fueled his dedication to understanding and combating autoimmune diseases, ultimately contributing to significant advancements in the field 1.

       

    Overcoming Challenges

    In the pursuit of developing treatments for autoimmune diseases, has faced numerous challenges. He emphasizes the importance of raising awareness to ensure people benefit from medical advances 2. Scott Benner

    I found everything about this hour to be incredibly uplifting and hopeful.

    ---

    Despite the obstacles, Francisco remains optimistic about the future of diabetes treatment and the potential for breakthroughs in restoring beta cell function 3.

Related Episodes